Targeting Cancer Signaling Pathways by Nimbolide A review on Chemoprevention and Therapeutic Studies

Mohd Owais Ansari, Shadab Ggha and Hifzur R Siddique
Additional contact information
Hifzur R Siddique: Department of Zoology, Aligarh Muslim University, India

Cancer Therapy & Oncology International Journal, 2017, vol. 8, issue 4, 66-70

Abstract: Neem (Azadirachta indica), has been in use as a traditional medicine since ancient time. Nimbolide, a phytochemical from neem has attracted the cancer scientists as a potential natural molecule for the effective cancer prevention and therapy. The researchers also highlight the efficiency and efficacy of nimbolide in different experimental systems. Moreover, nimbolide does not have the side effects in vivo model systems. The importance of nimbolide in cancer prevention and therapy is very high because nimbolide targets multiple signaling pathways which are involve in cell proliferation, cell cycle, apoptosis, invasion, metastasis and angiogenesis. However, more experimental proofs are needed to validate nimbolide application in cancer prevention and therapy. In this mini-review, we discuss different recent findings to target signaling molecules in different preclinical cancer. the important discoveries related to nimbolide against different preclinical cancer models. We also discuss the possibilities to use nimbolide as preventive and therapeutic molecule against the dreaded disease cancer.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555741.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555741.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:8:y:2017:i:4:p:66-70

DOI: 10.19080/CTOIJ.2017.08.555741

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().